本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

1.99
-0.2200-9.95%
盘后1.90-0.0900-4.52%19:39 EDT
成交量:168.56万
成交额:340.86万
市值:3.16亿
市盈率:-6.81
高:2.17
开:2.14
低:1.93
收:2.21
数据加载中...
2025/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/26

重要事件披露

Form 8-K - Current report
2025/01/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/03

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities